What will the prevailing sentiment be about Rapamycin as a longevity drug in 2028?
💎
Premium
6
Ṁ277
2028
11%
Wonder-drug: Most adults should consider it
22%
Valuable but imperfect: Some healthy adults should consider it, but there are major drawbacks
25%
Unproven but promising: Too early to tell
30%
Ineffective: Any benefits are too small to be worth the drawbacks
12%
Harmful/scandalous: Clear serious drawbacks that last beyond cessation of treatment

I'll post a proposed resolution here for discussion at least one week before resolving. May resolve to a mixture of up to two different choices in borderline cases.

If there's any substantial disagreement, I'll ask a popular LLM-style chatbot to select a resolution based on the title of the market, the choices, and the text of the ten first Google News results for "rapamycin for longevity".

Get
Ṁ1,000
and
S3.00
© Manifold Markets, Inc.Terms + Mana-only TermsPrivacyRules